Risk of infections and cardiovascular and venous thromboembolic events associated with JAK inhibitors in rheumatoid arthritis: protocols of two systematic reviews and network meta-analyses

INTRODUCTION: Janus kinases (JAK) inhibitors demonstrated to be effective in the treatment of adult patients with moderate-to-severe active rheumatoid arthritis (RA) but have been associated with serious cardiovascular and serious events. Two systematic reviews and network meta-analyses will be carr...

Descripción completa

Detalles Bibliográficos
Autores principales: Alves, Carlos, Penedones, Ana, Mendes, Diogo, Batel-Marques, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780510/
https://www.ncbi.nlm.nih.gov/pubmed/33384392
http://dx.doi.org/10.1136/bmjopen-2020-041420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780510/
https://www.ncbi.nlm.nih.gov/pubmed/33384392
http://dx.doi.org/10.1136/bmjopen-2020-041420

Ejemplares similares